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Objective: To determine whether treatment outcome is associated with visualization of contrast extravasation in patients 
with acute massive gastrointestinal bleeding after endoscopic failure.
Materials and Methods: From January 2007 to December 2009, patients that experienced a first attack of acute 
gastrointestinal bleeding after failure of initial endoscopy were referred to our interventional department for intra-arterial 
treatment. We enrolled 79 patients and divided them into two groups: positive and negative extravasation. For positive 
extravasation, patients were treated by coil embolization; and in negative extravasation, patients were treated with intra-
arterial vasopressin infusion. The two groups were compared for clinical parameters, hemodynamics, laboratory findings, 
endoscopic characteristics, and mortality rates.
Results: Forty-eight patients had detectable contrast extravasation (positive extravasation), while 31 patients did not 
(negative extravasation). Fifty-six patients survived from this bleeding episode (overall clinical success rate, 71%). An 
elevation of hemoglobin level was observed in the both two groups; significantly greater in the positive extravasation 
group compared to the negative extravasation group. Although these patients were all at high risk of dying, the 90-day 
mortality rate was significantly lower in the positive extravasation than in the negative extravasation (20% versus 42%, p 
< 0.05). A multivariate analysis suggested that successful hemostasis (odds ratio [OR] = 28.66) is the most important 
predictor affecting the mortality in the two groups of patients.
Conclusion: Visualization of contrast extravasation on angiography usually can target the bleeding artery directly, resulting 
in a higher success rate to control of hemorrhage.
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INTRODUCTION
Patients with acute massive gastrointestinal bleeding are 
a most challenging group because this disease is associated 
with a high mortality rate. Acute massive gastrointestinal 
bleeding involves symptoms of hematemesis, melena, 
or hematochezia that causes hemodynamic instability 
(hypotension with systolic blood pressure < 90 mmHg) or 
required transfusion of at least four units of blood within Korean J Radiol 12(5), Sep/Oct 2011 kjronline.org 569
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24 hours of symptoms of acute bleeding. By anatomic 
definition, the blood loss proximal to the ligament of 
Treitz, from the esophagus, stomach or duodenum, is 
defined as upper gastrointestinal hemorrhage. And, the 
lower gastrointestinal hemorrhage is bleeding distal to the 
ligament of Treitz that originates from the small intestine 
or colon. Advanced age, rebleeding, respiratory failure, 
coagulopathy and co-morbidities are the most important 
risk factors for mortality (1-6). However, the etiologies 
and risks of patients with acute massive gastrointestinal 
bleeding are complex and often require a multi-specialty 
approach to treatment (7). 
Early fluid resuscitation, rapid assessment of the rate and 
volume of blood loss, the appearance of the expelled blood, 
hypotension, presence of shock and coagulopathy are all 
important determinants of treatment strategy (7). After 
patient stabilization, endoscopy is often used to detect 
active bleeders and to achieve hemostasis; however, this 
primary hemostatic procedure has a 10-30% failure rate (8-
10). If the patient still exhibits ongoing bleeding (> 1 mL/
min) after endoscopy or if primary hemostasis cannot be 
achieved using endoscopic techniques, further aggressive 
treatment with intra-arterial embolization or surgical 
intervention is necessary.
Intra-arterial treatment is an alternative method for 
control of hemorrhage. When patients undergo angiography, 
the intra-arterial treatment strategy (coil embolization 
or vasopressin infusion) is usually based on visualization 
of contrast extravasation. Contrast extravasation on 
angiography is strong evidence of ongoing bleeding and 
may facilitate embolization of active bleeders (11-13). In 
our experience, if active extravasation of contrast material 
was identified on angiography, the target vessel was treated 
via superselective transarterial embolization. And, if active 
extravasation was not demonstrated by the angiographic 
procedure, the patient was treated by vasopressin infusion. 
By the two different ways of intra-arterial treatment, the 
angiographic sign of contrast extravasation may affect 
therapeutic strategy. In this study, we retrospectively 
compared the clinical characteristics, endoscopic findings, 
as well as the 30-day and 90-day mortality rates of 
acute massive gastrointestinal bleeding patients in who 
contrast extravasations were detected or not detected on 
angiography. The purpose of this retrospective study was to 
determine whether treatment outcome is associated with 
this angiographic sign.
MATERIALS AND METHODS
Patient Population
This study was conducted retrospectively at a tertiary 
referral medical centre from January 2007 to December 
2009. The study was approved by the institutional review 
board for human investigation, and written informed 
consent was waived because of strict maintenance of 
patient anonymity and the observational nature of 
the study. A search of the institutional database for 
interventional radiology identified 92 consecutive patients 
who experienced a first attack of acute gastrointestinal 
bleeding after the failure of an endoscopic examination was 
referred for intra-arterial treatment. Patients with acute 
massive gastrointestinal bleeding who directly underwent 
surgery were not enrolled in the study. Endoscopic failure 
was defined as failure to detect the source of bleeding using 
endoscopy or failure to achieve primary hemostasis. Acute 
massive gastrointestinal bleeding was deemed to have 
occurred if either of the following two criteria was met: 
hemodynamic instability (hypotension with systolic blood 
pressure < 90 mmHg) during the angiographic procedure or 
transfusion of at least four units of blood within 24 hours 
of symptoms of acute bleeding. We excluded four patients 
because of a history of gastro-esophageal varices associated 
with liver cirrhosis or portal hypertensive gastropathy. Nine 
patients with stable vital signs during angiography who did 
not fulfill the aforementioned definition of acute massive 
gastrointestinal bleeding were also excluded. Thus, our 
study population consisted of 79 patients (M:F = 49:30; 
mean age, 68.4 years; range, 21-94 years).
The clinical manifestation and laboratory data of each 
patient were recorded after reviewing their medical charts. 
Data were collected on demographic characteristics, 
appearance of expelled blood, hemodynamic status, 
laboratory findings, co-morbidities, use of adjuvant therapy, 
endoscopic findings, angiographic interventions, rebleeding, 
and mortality. The possible cause of mortality was also 
recorded by reviewing the patient medical charts. Patients 
who met one of the following criteria were identified as 
having bleeding tendency: 1) international normalized ratio 
greater than 1.6, 2) partial thromboplastin time greater 
than 45 sec, or 3) thrombocytopenia with a platelet count 
less than 50,000 per cubic millimeter (5 x 10
10 per liter). 
Missing or implausible data were identified and corrected 
after consultation with the patient’s physician.Korean J Radiol 12(5), Sep/Oct 2011 kjronline.org 570
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Angiography and Embolization Technique
In our interventional radiology section, all procedures 
were performed in a similar fashion by three interventional 
radiologists, whose experience ranged from 6 to 20 years. 
Continuous electrocardiographic and pulse oximetry 
cardiopulmonary monitoring were performed by a nurse 
throughout the procedure; if necessary, intravenous 
sedation was administered or intubation was performed by 
an anesthesiologist. At the commencement of angiography, 
a 5-Fr introducer was inserted into the common femoral 
artery under local anesthesia. The celiac trunk and superior 
mesenteric artery were routinely examined using a 4.1-
Fr catheter (Cook Incorporated, Bloomington, IN). The 
inferior mesenteric artery and iliac arteries were selectively 
checked if there was suspected bleeding in the distal colon 
or rectum. If indicated, we used a 2.7-Fr microcatheter 
system (Terumo Corporation, Tokyo, Japan) to approach the 
target vessel. Iodinated contrast medium (Ultravist, Bayer 
Schering Pharma AG, Berlin, Germany; iodine content, 300 
mg/mL) was used.
If active extravasation of contrast material was 
identified on angiography, the target vessel was treated via 
superselective transarterial embolization. The target vessels 
were embolized using metallic coils (and in some cases, 
coils supplemented with a Gelatin sponge) to the point of 
flow stasis. We used 0.035-inch stainless macrocoils (Cook 
Incorporated) or 0.018-inch platinum microcoils (Boston 
Scientific, Ireland) for embolization. The procedure was 
considered technically successful if there was complete 
occlusion of the target vessel. An example of successful 
treatment of active bleeding from the right colic artery 
is shown in Figure 1. If active extravasation was not 
demonstrated by the angiographic procedure, the patient 
was treated with intra-arterial administration of vasopressin 
for two days via a catheter extending to the suspected 
target vessel (most commonly the gastro-duodenal artery 
or the superior mesenteric artery). In such cases, the 
suspected target vessel was selected on the basis of clinical 
appearance of the patient and the appearance of the 
expelled blood on endoscopy. Vasopressin administration 
typically began with a loading dose of 0.2 U/min, which 
was then increased to a maximum of 0.4 U/min, followed 
by tapering of the dose over 12-24 hours.
Clinical Follow Up
A successful hemostasis was defined as the cessation 
of active bleeding and stabilization of the hemoglobin 
levels. Clinical success was defined as a patient surviving 
Fig. 1. 54-year-old woman presented with acute melena and hemodynamic instability. Emergent endoscopy was performed and revealed 
bleeding ulcer over ascending colon. Bleeding site was difficult to access, and failed to reach hemostasis by endoscopy. Before angiography, 
woman was transfused with 8 units of blood.  
A. Angiography showed active extravasation of contrast medium from branch of superior mesenteric artery (right colic artery) in ascending 
colon (arrow). B. After embolization with metallic coils, superselective arteriography of right colic artery demonstrated that bleeding artery was 
completely occluded by coils and there was no further extravasation of contrast medium. Patient recovered and stopped melena in one day after 
angiographic intervention and was discharged from our hospital one week later. 
A BKorean J Radiol 12(5), Sep/Oct 2011 kjronline.org 571
Intra-Arterial Treatment of Acute Massive GI Bleeding after Endoscopic Failure
90 days from this bleeding episode. The follow-up medical 
records were reviewed to determine whether the patients 
experienced ongoing blood loss and whether subsequent 
surgery or repeat angiographic procedures were required. 
After completion of the angiographic intervention, a 
rebleeding episode was defined as a subsequent bleeding 
episode with a drop in hemoglobin of 2 g/dL, that occurred 
after the initial bleed had stopped within 72 hours. The 
30-day and 90-day mortality rates were recorded. We also 
checked whether the patient had further blood transfusions 
to replace ongoing blood loss, whether the patient required 
further intervention in the form of a repeat embolization 
or surgery to stop bleeding, and whether the patient 
died because of acute hemorrhage or hemorrhage-related 
complications. 
Statistical Analysis
Statistical analyses were performed using SPSS version 
14.0 (SPSS INC., IBM Company, Chicago, IL). Descriptive 
statistics are expressed as the mean ± standard deviation 
(SD) and range for continuous variables. Categorical 
variables are expressed as frequencies and percentages. 
A one-way ANOVA was used to compare the two groups 
of patients. A p value of < 0.05 was considered to be 
statistically significant. Survival was estimated using the 
Kaplan-Meier method. In order to find out the potential risk 
factors for 90-day mortality, a univariate logistic regression 
analysis was conducted with age, gender, presence of shock, 
number of blood transfusions, rebleeding, cormorbidities, 
time intervals between endoscopic failure to angiography, 
location of acute bleeding (upper or lower), treatment 
methods (coil embolization versus vasopressin infusion), 
successful hemostasis and laboratory values (including 
hemoglobin, creatinine, platelet counts, presence of 
metabolic acidosis and bleeding tendency) as factors. A 
multivariate analysis was conducted using the significant 
Table 1. Comparison of Clinical Variables in Patients with Acute Massive Gastrointestinal Bleeding
Positive Extravasation (n = 48) Negative Extravasation (n = 31) P Value
Clinical characteristics
Sex (M:F) 33:15 15:16    0.07
Age (mean age ± SD) 69.0 ± 16.5 67.4 ± 17.9    0.53
Hypovolemic shock 26 (54%) 16 (52%)    0.82
Intubation with endotracheal tube   6 (13%)   5 (16%)
Units of blood transfusion  
  24 hours before angiography
9.0 ± 2.6 8.7 ± 2.7    0.61
Rebleeding 13 (27%)   6 (19%)    0.43
90-day Mortality 10 (20%) 13 (42%)    0.04*
Cause of mortality    0.55
Bleeding-related multiple organ failure   3 (6%)   4 (13%)
Hypovolemic shock   2 (4%)   5 (16%)
Sepsis   4 (8%)   2 (7%)
Underlying disease   1 (2%)   2 (7%)
Appearance of the expelled blood
Fresh blood 42 (88%) 15 (48%) < 0.001*
Blood clot/tarry stool 10 (21%)   5 (16%)    0.60
Coexisting illness
Peptic ulcerative disease 30 (63%) 22 (71%)    0.44
Heart disease   2 (2%)   4 (13%)    0.15
Liver disease   4 (8%)   2 (7%)    0.76
Renal disease   9 (19%)   6 (19%)    0.95
Tumor of GI tract   6 (13%)   3 (10%)    0.70
Post-surgery complications   1 (2%)   0 (0%)    0.42
Note.— Data are expressed as number of patients; data in parentheses are expressed as percentages. P value < 0.05 are 
statistically significant and are marked with asterisk (*). F = female, GI = gastrointestinal, M = male, SD = standard deviationKorean J Radiol 12(5), Sep/Oct 2011 kjronline.org 572
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risk factors on the univariate analysis.
RESULTS
Clinical Variables between the Positive and Negative 
Extravasation Groups
Our study population consisted of 79 patients. Forty-
eight patients had detectable contrast extravasation 
(positive extravasation group), while 31 patients did not 
(negative extravasation group). The clinical characteristics; 
appearance of the expelled blood and coexisting illnesses 
in patients with acute massive gastrointestinal bleeding, 
are summarized in Table 1. All 79 patients were resuscitated 
in the intensive care unit or in the emergency ward. There 
were no significant differences in sex, age, incidence of 
hypovolemic shock or units of blood transfused 24 hours 
before angiography. Eleven patients (14%) were intubated 
before or during the angiographic procedure and a mean of 
8.9 units of blood (range, 4-16 units) were administered 24 
hours before the procedure. Mortality differed significantly 
between the positive and negative extravasation groups 
(20% and 42%, respectively; p < 0.05), but the rebleeding 
rate did not differ between the two groups. Bleeding-
related multiple organ failure and hypovolemic shock were 
the most common causes of mortality in the both groups 
of patients. The appearance of the expelled blood was 
classed as fresh blood in 57 instances (n = 42 in positive 
extravasation group; and n = 15 in negative extravasation 
group; 88% versus 48%) and as clotted blood or melena 
in 15 instances. The incidence of blood expelled as fresh 
blood differed between the two groups (48% versus 88%, p 
< 0.05). The most common co-morbidity in the positive and 
negative extravasation groups was peptic ulcerative disease 
(n = 30 in positive extravasation group, n = 22 in negative 
extravasation group; 63% and 71%, respectively).
Estimated Endoscopic Etiologies, Adjuvant Therapy, 
and Intra-Arterial Treatment between the Positive and 
Negative Extravasation Groups
Table 2 shows a comparison of the estimated endoscopic 
Table 2. Comparison of Estimated Endoscopic Etiologies, Adjuvant Therapy, and Intra-Arterial Treatment in Patients 
with Acute Massive Gastrointestinal Bleeding
Positive Extravasation (n = 48) Negative Extravasation (n = 31) P Value
Location of bleeding    0.69
Upper (proximal to Treitz ligament) 18 (38%) 13 (42%)
Lower (distal to Treitz ligament)  30 (63%) 18 (58%)
Bleeding tendency 23 (48%) 13 (42%)    0.60
Estimated etiologies by endoscopy
No detectable lesion   5 (10%) 17 (55%) < 0.001*
Cancer of GI tract   6 (13%)   3 (10%)    0.70
Clean non-bleeding ulcer   6 (13%)   2 (7%)    0.38
Bleeding ulcer 31 (65%)   9 (29%) < 0.001*
Time from endoscopic failure to angiography 7.7 ± 6.6 9.2 ± 5.1    0.27
Selected artery for intra-arterial treatment    0.50
GDA and its branches 12 (25%)   9 (29%)
SMA and/or its branches 25 (52%) 18 (58%)
IMA and/or its branches   8 (17%)   4 (13%)
Iliac artery and/or its branches   3 (6%)   0 (0%)
Use of adjuvant therapy    0.30
Vitamin C and K 16 (33%) 20 (65%)
H2 blockers (famotidine)   6 (13%)   3 (10%)
Proton pump inhibitors (pantoprazole)   9 (19%)   5 (16%)
Note.— Definition of intra-arterial treatment includes coil embolization and vasopressin infusion. Data are expressed as number 
of patients. Data in parentheses are percentages, unless otherwise indicated. P value < 0.05 are statistically significant and 
marked with an asterisk (*). GDA = gastroduodenal artery, GI = gastrointestinal, IMA = inferior mesenteric artery, SMA = superior 
mesenteric arteryKorean J Radiol 12(5), Sep/Oct 2011 kjronline.org 573
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etiologies, adjuvant therapy, and intra-arterial treatment 
between the two groups of patients. Upper gastrointestinal 
endoscopy was performed on all 79 patients. A bleeding 
ulcer was the most common endoscopic finding (31 of 
48, 65%) in the positive extravasation group, compared 
with no detectable lesion (17 of 31, 55%) in the negative 
extravasation group. Of the endoscopic findings, the 
incidence of bleeding ulcers and the incidence of the 
absence of detectable lesions differed between the two 
groups (p < 0.01). Due to acute gastrointestinal bleeding, 
which is typically intermittent in nature, the endoscopic 
finding of non-bleeding ulcer found in the two groups did 
not show evidence of bleeding at the time of endoscopy, 
but they still presented symptoms of acute blood loss after 
endoscopic hemostasis. None of the patients underwent a 
push enteroscopy or balloon-assisted gastroscopy. Of the 
79 patients, 24 (30%) also underwent a colonoscopy, which 
revealed a massive amount of fresh and old blood in the 
course of the colon. The mean time from endoscopic failure 
to angiography in the 79 patients was 8.3 hours (range, 60 
min to 35 hr). In this study, patients with positive contrast 
extravasation (n = 48) all underwent a coil embolization 
in the selected bleeding artery, including 12 (25%) in 
gastro-duodenal artery, 25 (52%) in superior mesentery 
artery, eight (17%) in inferior mesentery artery, and three 
(6%) in iliac artery. In contrast; patients with negative 
contrast extravasation (n = 31) underwent an intra-arterial 
vasopressin infusion; nine (29%) in the gastro-duodenal 
artery, 18 (58%) in superior mesentery artery, and four 
(13%) in inferior mesentery artery. However, there is no 
statistical difference of these bleeding arteries between the 
two groups (p = 0.5). Fifty-eight patients (73%) received 
adjuvant therapy consisting of vitamins (n = 36), H2 
blockers (n = 9), and proton pump inhibitors (n = 13). 
Hemodynamic and Laboratory Characteristics between 
the Positive and Negative Extravasation Groups
Table 3 lists hemodynamic and laboratory findings for 
the two groups of patients. Hemoglobin concentration 
was lower in the positive extravasation group than in the 
negative extravasation group (p < 0.05). After embolization, 
an elevation in hemoglobin level was observed in both 
the positive and negative extravasation groups, and was 
significantly greater in the positive extravasation group 
Table 3. Correlation of Hemodynamic and Laboratory Characteristics in Patients with Acute Massive Gastrointestinal 
Bleeding
Positive Extravasation (n = 48) Negative Extravasation (n = 31) P Value
Hemodynamic status at presentation
Systolic blood pressure (mm Hg) 91.6 ± 19.8 93.6 ± 20.6 0.67
Pulse rate (beats/min) 99.0 ± 22.3 95.6 ± 17.1 0.47
Laboratory characteristics
Hemoglobin concentration 
at presentation (g/dL) 6.7 ± 1.9 7.9 ± 1.8 0.01*
24 hours after angiography (g/dL) 11.0 ± 2.0 10.0 ± 2.3 0.04*
Platelet 143.4 ± 108.6 175.0 ± 123.9 0.24
Aspartate aminotransferase (U/l) 85.1 ± 264.3 72.8 ± 129.1 0.82
Alanine aminotransferase (U/l) 75.9 ± 231.2 52.3 ± 82.7 0.65
Blood urea nitrogen level 45.9 ± 37.2 45.8 ± 39.2 0.99
Creatinine level 1.9 ± 2.0 1.9 ± 2.2 0.90
Arterial blood gas- pH (acidity) 7.4 ± 0.1 7.4 ± 0.2 0.18
Arterial blood gas- Bicarbonate 21.6 ± 4.0 20.9 ± 6.8 0.68
Bleeding tendency 0.62
Yes 13 (27%) 10 (32%)
No 35 (73%) 21 (68%)
Note.— Data are expressed as mean ± standard deviation. P value < 0.05 is statistically significant and marked with asterisk (*). 
Definition of intra-arterial treatment includes coil embolization and vasopressin infusion. Definition of bleeding tendency includes 
at least one of following criteria: 1) international normalized ratio greater than 1.6, 2) partial thromboplastin time greater than 
45 sec, or 3) thrombocytopenia with platelet count less than 50,000 per cubic millimeter (5 x 10
10 per liter).Korean J Radiol 12(5), Sep/Oct 2011 kjronline.org 574
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compared to the negative extravasation group (p < 0.05). 
There was no difference in hemodynamic status (systolic 
blood pressure or pulse rate) between the groups at 
presentation. The other laboratory data (platelet count, 
liver and renal function and arterial blood gas level) at 
presentation did not differ between the groups. Bleeding 
tendency showed no statistical difference between the two 
groups (n = 13 in positive extravasation, n = 10 in the 
negative extravasation group, and p = 0.62). 
Follow-Up Studies and Short-Term Outcomes
Fifty-six patients (n = 38 for the positive extravasation 
group, and n = 18 for the negative extravasation group; 
79% versus 58%) survived from this bleeding episode. The 
overall clinical success rate was 71%. Moreover, the overall 
median time from endoscopic failure to angiography in the 
79 patients was 6.4 hours (range, 60 min to 20 hr), and 
there was no significant difference in the time interval 
between the positive and negative extravasation groups (7.7 
± 6.6 versus 9.2 ± 5.1; p = 0.27). A successful hemostasis 
was recorded and showed no statistical difference between 
the two groups (n = 38 for the positive extravasation group, 
n = 20 for the negative extravasation group, and p > 0.05). 
In ten positive extravasation patients that experienced 
a failed coil embolization, seven underwent surgery, two 
underwent a second angiographic embolization and one 
refused a secondary intervention. In eleven negative 
extravasation patients without successful hemostasis, 
nine underwent surgery and two died without receiving 
any further intervention. Rebleeding rate also did not 
differ between the two groups (p = 0.43). At follow-up, 19 
patients experienced rebleeding; six patients (6 of 31, 19%) 
in the negative extravasation group and 13 (13 of 48, 27%) 
in the positive extravasation group. Twenty-three patients 
(overall mortality, 29%) died within 90 days. The Kaplan-
Meier technique showed there was no difference between 
the groups for 30-day mortality, but 90-day mortality was 
significantly higher in the negative extravasation group 
compared to the positive extravasation group (42% versus 
20%, p < 0.05). The relative survival curves are presented 
in Figure 2. In the period of the 90th day to the one-year 
follow-up, we found that there was two additional patients 
in the positive extravasation group that died of sepsis and 
their underlying disease, and no additional patient in the 
negative extravasation died during this period. 
Post-procedural complications included inguinal 
hematoma, bowel ischemia and acute renal failure. In 
the positive extravasation group, we found two inguinal 
hematomas, one bowel ischemia, and one acute renal 
failure; in the extravasation group, one inguinal hematoma 
and one acute renal failure. No bowel ischemia was noted in 
negative extravasation group.
A univariate and multivariate logistic regression analysis 
for the potential risk factors was listed in Table 4. The 
univariate analysis showed that successful hemostasis (odds 
ratio [OR] = 36.83; 90% CI: 9.3-146.2), presence of shock 
(OR = 3.51; 90% CI: 1.21-10.24), bleeding tendency (OR 
= 3.36; 90% CI: 1.19-9.49), rebleeding (OR = 2.96; 90% 
CI: 1.00-8.72), and treatment methods (OR = 2.74; 90% 
CI: 1.01-7.44) are significantly associated with mortality 
after intra-arterial treatment. For the multivariate analysis, 
we found that successful hemostasis (OR = 28.66; 90% CI: 
6.53-125.68; p < 0.01) is the most important predictor 
affecting the mortality in the two groups of patients.
DISCUSSION
Our study revealed that successful therapeutic 
embolization is usually associated with visualization of 
contrast extravasation (20% mortality in the positive 
extravasation group versus 42% mortality in the negative 
extravasation group). An angiographic sign of contrast 
extravasation is a direct indication of a bleeding artery, 
and subsequent coil embolization is more effective in 
Fig. 2. Kaplan-Meier technique showed relative survival curves 
at day 90. *p < 0.05.
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terminating acute massive gastrointestinal bleeding than 
intra-arterial vasopressin infusion therapy. We found that 
angiography with subsequent therapeutic embolization 
was successful in controlling hemorrhage in 56 (71%) 
of 79 patients. Although there is still controversy about 
the preferred bleeder localization and treatment method 
for patients experiencing acute life-threatening blood 
loss after endoscopic failure, it is always important to 
detect the bleeding artery as soon as possible to optimize 
treatment and decrease mortality (14). This may be 
achieved way of surgery or transarterial angiography (13). 
However, surgical interventions are invasive, may cause 
hypoxia in hemodynamically unstable patients, and require 
general anesthesia, which may cause cardiac arrhythmia, 
bronchospasm, and even sudden death. The advantages of 
angiography are that it is less invasive than surgery and 
often does not require general anesthesia. In addition, 
therapeutic embolization and intra-arterial vasopressin 
infusion can be performed during the procedure.
In clinical practice, it is assumed that the selection of 
intra-arterial treatment (coil embolization or vasopressin 
infusion) is usually based on visualization of contrast 
extravasation on angiography. Patients with positive 
contrast extravasation can be directly treated for a bleeding 
artery and undergo a guided coil embolization of the active 
bleeder. In patients who do not have angiographic signs of 
contrast extravasation (negative contrast extravasation), 
the catheter is often placed in the suspected target 
artery for intra-arterial vasopressin infusion therapy. In a 
retrospective study of 47 patients (15), Gomes et al. (15) 
compared the effectiveness of intra-arterial vasopressin 
infusion with that of transarterial embolization therapy 
in patients with acute major gastrointestinal hemorrhage. 
Contrast extravasation was noted in all of their patients on 
angiography, and the overall success rate with embolization 
therapy was significantly higher than that of intra-arterial 
vasopressin therapy (88% versus 52%, respectively). We 
saw similar results in our study. The clinical success rate 
was 79% in the positive extravasation group (treated with 
embolization) and 58% in the negative extravasation group 
(treated with vasopressin infusion). Although both a coil 
embolization and intra-arterial vasopressin infusion have a 
therapeutic effect on the control of acute gastrointestinal 
hemorrhage, Gomes et al. (15) concluded that a coil 
embolization offers several advantages over intra-arterial 
vasopressin infusion, including a more permanent and faster 
Table 4. Potential Risk Factors for Mortality: Multivariate Logistic Regression Results
Variables
Univariate Logistic Regression Multivariate Logistic Regression
OR (95% CI) P Value OR (95% CI) P Value
Successful hemostasis  36.83 (9.30 ± 146.2) < 0.01* 28.66 (6.53 ± 125.68) < 0.01*
Rebleeding   2.96 (1.00 ± 8.72)   0.04*   3.17 (0.60 ± 16.76)  0.17
Bleeding tendency   3.36 (1.19 ± 9.49)   0.02*   1.88 (0.42 ± 8.43)  0.41
Presence of shock   3.51 (1.21 ± 10.24)   0.02*   2.96 (0.64 ± 13.73)  0.16
Treatment methods   2.74 (1.01 ± 7.44)   0.04*   3.54 (0.81 ± 15.59)  0.19
Bleeding peptic ulcer   1.77 (0.65 ± 4.81)  0.27
Age   1.02 (0.099 ± 1.05)  0.23
Gender   1.21 (0.44 ± 3.34)  0.71
Units of blood transfusion   1.11 (0.92 ± 1.33)  0.29
Time intervals    0.97 (0.88 ± 1.06)  0.46
Location of acute bleeding   1.01 (0.37 ± 2.72)  0.99
Laboratory values
Hemoglobin level at presentation   0.87 (0.68 ± 1.12)  0.27
Creatinine   1.02 (0.81 ± 1.29)  0.85
Platelet counts   1.00 (0.99 ± 1.00)  0.23
Presence of metabolic acidosis   0.57 (0.21 ± 1.54)  0.27
Note.— Data are expressed as OR (95% CI). P value < 0.05 is statistically significant and marked with asterisk (*). Multivariate 
analysis was conducted with significant risk factors on univariate analysis. Treatment methods include coil embolization and intra-
arterial vasopressin infusion. OR (95% CI) indicates odds ratio (95% confidence interval). Time intervals indicate period between 
endoscopic failure to angiography. OR = odds ratioKorean J Radiol 12(5), Sep/Oct 2011 kjronline.org 576
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control of hemorrhage and lower mortality rate. 
To our knowledge, there were only older scientific 
papers to evaluate the efficacy and safety of intra-arterial 
vasopressin infusion in patients with angiographic signs 
of acute gastrointestinal bleeding (16, 17). With modern 
transarterial embolization techniques, coil embolization 
has advantages over vasopressin infusion therapy in terms 
of quicker completion of therapy and decreased likelihood 
of systemic complications (18). However, in some difficult 
cases, especially when superselective catheterization is 
technically difficult to approach or for multiple bleeders, 
vasopressin is still preferable. It has been well known 
that mesenteric arterial constriction in response to 
vasopressin infusion may cause unfavorable complications 
(e.g. intestinal ischemia) (19, 20). Further clarification 
of the role of vasopressin infusion in patients with no 
angiographic sign of active bleeding requires prospective 
randomized controlled trials or meta-analyses.
Treatment of lesions that exhibit positive extravasation of 
contrast material using embolization reportedly has a high 
success rate, presumably because it targets the bleeding 
artery directly (13, 21-23). Padia et al. (24) evaluated the 
effectiveness of coil embolization in a large series of 108 
patients with acute upper gastrointestinal hemorrhage, 
with or without contrast extravasation on angiography. In 
patients without contrast extravasation on angiography, 
Padia et al. (24) performed blind embolizations of the 
gastro-duodenal artery using coils. The treatment success 
rate and short-term outcome (30-day mortality) did not 
differ between the two groups, even though the negative 
extravasation group had a higher incidence of co-morbidity 
with respiratory compromise. Similarly, our results also 
showed that 30-day mortality was similar for the two 
groups; however, the 90-day mortality differed significantly 
between our two groups. We believe that, although both 
embolization methods can temporarily stop bleeding, 
coil embolization is better for permanent cessation of 
acute massive gastrointestinal bleeding than intra-arterial 
administration of vasopressin, and has a success rate similar 
to that of surgery.
Although we found that the rebleeding rate in negative 
extravasation group is lower than positive extravasation 
group, the short-term (90-days) and long-term (one-year) 
mortality rates are still higher in the negative extravasation 
group. When analysing the cause of death, patients with 
bleeding from an unknown origin may have a higher 
propensity die of hypovolemic shock or bleeding-related 
multiple organ failure during an acute episode of bleeding, 
and because of the difficulty in identifying the active 
bleeders, the mortality rate is higher than the positive 
extravasation group. Moreover, it was concluded that 
patients with negative bleeders on angiography died soon 
after without a timely hemostasis. We thought that the use 
of vasopressin infusion in the negative extravasation group 
could not effectively stop acute massive gastrointestinal 
bleeding in a timely manner (25). Based on our results, 
alternative methods such as early surgical intervention 
should be considered in patients with negative angiographic 
findings of contrast extravasation. 
A variety of embolic agents such as Gelatin sponges, 
metallic coils, polyvinyl alcohol, glue, N-butyl cyanoacrylate 
(NBCA), and autologous blood clots have been used in 
embolization for acute gastrointestinal bleeding (6, 26-28). 
The choice of the embolic agent usually depends on the 
diameter of the bleeding artery and the expected duration 
of the embolic effect. In our institution, we implant coils 
as close as possible to the bleeding artery and supplement 
them with Gelatin sponges to prevent rebleeding from 
potential collaterals. Like most interventional radiologists, 
we are reluctant to use liquid adhesives such as glue and 
NBCA because of the potential risk of bowel ischemia and 
the difficulty of handling liquid adhesives, although Toyoda 
et al. (29) reported that transarterial embolization using 
NBCA is life-saving for urgent hemostases and is particularly 
useful in cases of acute massive gastrointestinal bleeding 
and coagulopathy.
Our study has several limitations. First, there was a 
selection bias in our study population. Patients with 
acute massive gastrointestinal bleeding who received 
surgery without prior angiographic intervention were 
not included in the study. Moreover, we only included 
patients who fulfilled with the definition of acute massive 
gastrointestinal bleeding, that is hemodynamic instability 
(hypotension with systolic blood pressure < 90 mmHg) 
during the angiographic procedure or transfusion of at least 
four units of blood within 24 hours of symptoms of acute 
bleeding, and directly underwent angiography. Besides, 
the optimal time to perform angiography is a difficult 
clinical decision. Beyond this definition of acute massive 
gastrointestinal bleeding, it may be difficult to identify a 
definite source of bleeding on angiography patients with 
minor gastrointestinal hemorrhage (30). Radiologists may 
hesitate to perform angiography, and in this study, we 
also do not perform an angiography in such cases. Second, Korean J Radiol 12(5), Sep/Oct 2011 kjronline.org 577
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visualization of contrast extravasation is sometimes not 
objective. In a few cases, subtle or equivocal contrast 
extravasation on angiography makes it difficult to assess 
whether a patient had ongoing bleeding or not. Third, this 
study was retrospective. Although criteria were applied 
for transarterial embolization, the use of coils and the 
number of Gelfoam pieces used were not standardized. The 
experience of the three radiologists differed. Fourth, only 
a small number of our patients underwent CT angiography, 
although this method now has been proven to provide 
useful diagnostic value in patients with acute massive 
gastrointestinal bleeding. However, for dealing with 
emergent acute blood loss, we believe that angiography 
with timely transarterial embolization offers a more 
important therapeutic role that CT angiography cannot 
achieve.
In this study, we noted that patients with active 
massive gastrointestinal bleeding after endoscopic failure 
are at high risk of dying. Intra-arterial treatment (coil 
embolization or vasopressin infusion) is an alternative 
method to achieve hemostasis. However, visualization 
of contrast extravasation on angiography can target the 
bleeding artery directly and guide the coil embolization 
of the active bleeder. Among the two groups of patients, 
our findings suggest that patients with positive contrast 
extravasation on angiography have a higher survival rate 
than patients with negative contrast extravasation.
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